SPBP4H10.12 Antibody

What is SPBP4H10.12 and why is it important in fission yeast research?

SPBP4H10.12 is a protein found in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast . While specific functions of this protein remain under investigation, antibodies targeting SPBP4H10.12 serve as important tools for studying protein expression, localization, and interactions in S. pombe. Fission yeast is a widely used model organism in molecular biology due to its similarity to higher eukaryotes in cellular processes, making proteins like SPBP4H10.12 important targets for fundamental research in cell biology.

What are the key specifications of commercially available SPBP4H10.12 antibodies?

Commercial SPBP4H10.12 antibodies are typically available with the following specifications:

• UniProt accession number: Q9P7D6

• Host species: Typically rabbit or mouse

• Formats: Whole IgG, often available in 2ml or 0.1ml sizes

• Applications: Western blotting, immunoprecipitation, or other specified applications depending on the manufacturer

These antibodies are produced using specific immunogens derived from the SPBP4H10.12 protein sequence. The exact epitope targeted varies between manufacturers and should be verified before use in specific applications.

How should I validate the specificity of SPBP4H10.12 antibody for my experiments?

Proper validation of SPBP4H10.12 antibody requires multiple approaches:

• Knockout/knockdown controls: Use SPBP4H10.12 deletion mutants or RNAi knockdowns as negative controls. The antibody signal should be absent or significantly reduced in these samples .

• Overexpression controls: Express tagged SPBP4H10.12 and verify co-detection with both the antibody in question and an antibody against the tag.

• Cross-reactivity testing: Test the antibody against related proteins to ensure specificity.

• Application-specific validation: Validate separately for each application (Western blot, immunoprecipitation, etc.) as an antibody may work in one application but not another .

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide to verify that this blocks specific binding.

Remember that antibodies may perform differently in various experimental contexts. As demonstrated with Shb antibodies, some may work well for western blotting but not for immunoprecipitation, and vice versa .

How can I assess and minimize non-specific interactions of SPBP4H10.12 antibody?

Non-specific interactions can significantly impact experimental results. To assess and minimize these:

• Polyspecificity testing: Consider implementing flow cytometry-based polyspecificity assays that can detect antibody binding to unrelated targets. Similar to the PSP assay used for clinical antibodies, this approach can provide a quantitative measure of non-specific binding .

• Titration experiments: Determine the optimal antibody concentration that maximizes specific signal while minimizing background.

• Blocking optimization: Test different blocking agents (BSA, milk, serum) to identify the one that most effectively reduces non-specific binding.

• Buffer optimization: Adjust salt concentration, pH, and detergent content in wash buffers to improve specificity.

• Pre-adsorption: For tissues with known cross-reactivity issues, pre-adsorb antibodies against tissue lysates from knockout organisms.

Implementing these measures is crucial as polyreactive antibodies can compromise experimental results. Studies have shown that antibody polyspecificity can be quantitatively assessed, with scores above certain thresholds (e.g., PSP score >0.19) indicating potentially problematic antibodies .

What is the optimal protocol for using SPBP4H10.12 antibody in immunoprecipitation experiments?

For optimal immunoprecipitation with SPBP4H10.12 antibody:

• Cell lysis: Lyse S. pombe cells in a buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, supplemented with protease inhibitors. The approach used for S. pombe proteins in mitochondrial translation studies provides a useful reference .

• Pre-clearing: Pre-clear lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding.

• Antibody binding: Incubate cleared lysates with SPBP4H10.12 antibody (2-5 μg per mg of protein) overnight at 4°C with gentle rotation.

• Bead capture: Add protein A/G beads and incubate for 2-4 hours at 4°C.

• Washing: Perform at least 4 washes with lysis buffer containing reduced detergent (0.1-0.5%).

• Elution: Elute with either low pH buffer or by boiling in SDS sample buffer.

• Controls: Always include a negative control using non-specific IgG from the same species as the SPBP4H10.12 antibody. If possible, include an additional control using lysates from SPBP4H10.12 deletion strains.

This approach is similar to successful immunoprecipitation protocols used for other S. pombe proteins such as Ppr10-Myc and Mpa1, which were effectively co-immunoprecipitated to study protein-protein interactions .

How should I optimize Western blotting conditions for SPBP4H10.12 antibody?

Optimizing Western blotting for SPBP4H10.12 antibody requires:

• Sample preparation: For S. pombe proteins, use either TCA precipitation or direct lysis in hot SDS buffer to ensure complete protein extraction and denaturation.

• Gel percentage: Select appropriate gel percentage based on SPBP4H10.12 size (typically 8-12% for mid-sized proteins).

• Transfer conditions: Optimize transfer time and voltage based on protein size. For membrane-associated proteins, consider using semi-dry transfer with a mixed-mode buffer.

• Blocking optimization:

  • Test different blocking agents (5% milk, 3-5% BSA)

  • Determine optimal blocking time (typically 1-2 hours at room temperature or overnight at 4°C)

• Antibody dilution: Perform a dilution series (1:500 to 1:5000) to determine optimal concentration.

• Incubation conditions: Compare room temperature (1-2 hours) vs. 4°C (overnight) incubation.

• Washing stringency: Adjust detergent concentration (0.05-0.1% Tween-20) and number of washes.

• Detection system: Compare chemiluminescence vs. infrared imaging systems for sensitivity and quantification. For example, the Odyssey CLx infrared imaging system has been effectively used for detecting S. pombe proteins in western blots .

When optimizing these conditions, use positive controls with known expression of SPBP4H10.12 to benchmark your results.

How can SPBP4H10.12 antibody be used to study protein-protein interactions in S. pombe?

To study protein-protein interactions involving SPBP4H10.12:

• Co-immunoprecipitation (Co-IP): Use SPBP4H10.12 antibody to immunoprecipitate the protein complex, then detect interacting partners by Western blotting. This approach was successfully used to demonstrate the interaction between Ppr10 and Mpa1 in S. pombe .

• Reciprocal Co-IP: Perform reverse Co-IP using antibodies against suspected interaction partners, then detect SPBP4H10.12.

• Proximity labeling: Consider adapting BioID or APEX2 proximity labeling methods by fusing these enzymes to SPBP4H10.12, then using the antibody to verify expression.

• Sucrose gradient sedimentation analysis: Combine with Western blotting using SPBP4H10.12 antibody to detect protein complex formation, similar to the approach used to study Ppr10-Mpa1 association with mitochondrial ribosomal proteins .

• Quantitative analysis: Measure the strength of interactions using densitometry of Western blots or mass spectrometry following immunoprecipitation.

The approach used to demonstrate that "a fraction of Ppr10-Myc and Mpa1 was coimmunoprecipitated with Aco2-Mrpl49-FLAG" in S. pombe provides a methodological template that could be adapted for studying SPBP4H10.12 interactions .

What approaches can be used to investigate the function of SPBP4H10.12 in S. pombe?

To investigate SPBP4H10.12 function:

• Gene deletion/disruption: Create SPBP4H10.12 knockout strains and analyze phenotypes under different growth conditions (similar to studies of ppr10 and mpa1 deletion strains) .

• Domain mutation: Introduce specific mutations in functional domains and use the antibody to verify expression levels of the mutant protein.

• Protein localization: Use the antibody for immunofluorescence to determine subcellular localization.

• Conditional expression: Combine with regulated promoters to control SPBP4H10.12 expression and use the antibody to verify expression levels.

• Proteomics approach: Use the antibody for immunoprecipitation followed by mass spectrometry to identify interacting proteins, similar to the proteomic analysis that revealed co-purification of Ppr10 and Mpa1 with mitoribosomal proteins .

• Functional complementation: Express SPBP4H10.12 or mutant versions in deletion strains and use the antibody to confirm expression.

These approaches can be integrated to build a comprehensive understanding of SPBP4H10.12 function, similar to how the functional roles of Ppr10 and Mpa1 in mitochondrial translation were elucidated in S. pombe .

How do I quantify and statistically analyze Western blot results using SPBP4H10.12 antibody?

For rigorous quantification and analysis:

• Image acquisition: Use linear detection methods (such as the Odyssey CLx infrared imaging system) rather than film for more accurate quantification .

• Normalization:

  • Use housekeeping proteins appropriate for S. pombe (e.g., Cdc2, actin, tubulin)

  • Consider total protein normalization methods like Ponceau S staining as an alternative

• Quantification software: Use ImageJ/FIJI, ImageLab, or similar software to measure band intensities.

• Technical replicates: Perform at least three independent biological replicates.

• Statistical analysis:

  • For comparing two conditions: t-test (paired or unpaired as appropriate)

  • For multiple conditions: ANOVA followed by appropriate post-hoc tests

  • Report data as mean ± standard deviation or standard error

• Validation: Consider complementary methods to verify Western blot findings, such as qPCR for transcript levels or mass spectrometry for protein quantification.

Ensure consistent loading by quantifying total protein using methods like BCA protein assay and confirming by Ponceau S staining of membranes, as practiced in S. pombe protein studies .

What are common troubleshooting strategies for SPBP4H10.12 antibody experiments?

When troubleshooting:

• No signal in Western blot:

  • Verify protein transfer by Ponceau S staining

  • Decrease antibody dilution

  • Increase exposure time

  • Try different protein extraction methods specific for S. pombe

  • Consider different blocking agents

  • Verify antibody reactivity with positive control

• Multiple bands or high background:

  • Increase antibody dilution

  • Optimize blocking and washing steps

  • Try different blocking agents

  • Increase salt concentration in wash buffer

  • Confirm specificity with knockout controls

• Failed immunoprecipitation:

  • Adjust lysis conditions to preserve protein-protein interactions

  • Try different antibody amounts

  • Consider crosslinking antibody to beads

  • Verify if the antibody works for immunoprecipitation (as some antibodies work for Western blot but not IP, and vice versa)

• Inconsistent results:

  • Implement rigorous experimental design with proper controls

  • Use design of experiments (DOE) approach to systematically optimize multiple parameters simultaneously, similar to how DOE has been applied to optimize antibody purification processes

  • Document all experimental conditions meticulously

Always remember that antibody performance can vary significantly between applications, and validation in each specific application is essential .

How can new antibody technologies enhance SPBP4H10.12 research?

Emerging technologies that can enhance SPBP4H10.12 research include:

• Recombinant antibody development: Consider using high-throughput single-cell RNA and VDJ sequencing approaches to develop more specific recombinant antibodies against SPBP4H10.12, similar to the techniques used to develop antibodies against S. aureus protein A .

• Nanobodies and single-domain antibodies: These smaller antibody fragments offer advantages for certain applications, including improved penetration in fixed tissues and access to restricted epitopes.

• Antibody engineering: Custom engineering antibodies with specific properties (increased affinity, reduced non-specific binding) can improve experimental outcomes. Modern antibody engineering techniques can achieve nanomolar affinity (KD values around 10^-9 M), as demonstrated for other research antibodies .

• Multiplexed detection systems: Combine SPBP4H10.12 antibody with other antibodies in multiplexed imaging or protein array formats to study multiple proteins simultaneously.

• Integration with databases: Utilize antibody databases like PLAbDab to access and compare information about antibody sequences, structures, and properties to inform research design .

These technologies can significantly enhance the specificity and utility of antibodies in research settings, potentially addressing current limitations in SPBP4H10.12 studies.

What considerations are important when integrating SPBP4H10.12 antibody data with other omics approaches?

When integrating antibody data with other omics approaches:

• Data normalization: Develop appropriate normalization strategies when comparing antibody-based quantification with RNA-seq or proteomics data.

• Temporal considerations: Account for differences in timescales between transcriptional, translational, and post-translational events.

• Spatial information: Integrate localization data from antibody studies with other spatial omics techniques.

• Platform bias: Be aware of inherent biases in different methodologies and account for these in integrated analyses.

• Validation across platforms: Use orthogonal approaches to validate findings, similar to how both antibody-based detection and mass spectrometry have been used to verify protein interactions in S. pombe .

• Data integration tools: Utilize computational tools specifically designed for multi-omics data integration.

• Functional validation: Design experiments to functionally validate hypotheses generated from integrated omics analyses, similar to how functional assays were used to validate the role of Ppr10-Mpa1 complex in mitochondrial translation .

This integrated approach can provide a more comprehensive understanding of SPBP4H10.12 function within the broader cellular context of S. pombe biology.